Mediolanum International Funds’s Ascendis Pharma A/S ASND Stock Holding History

Mediolanum International Funds’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Buy	+11,697	New	+$2.73M	0.03%	331

Other funds holding ASND

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Mediolanum International Funds's ASND Position: Q2 2026 in Review

Mediolanum International Funds opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 11,697 shares worth $3.08M. The stake represents 0.03% of the portfolio and ranks #331 among its holdings.

34 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Mediolanum International Funds held 11,697 shares of Ascendis Pharma A/S worth $3.08M as of Q2 2026.
Ascendis Pharma A/S was a new Mediolanum International Funds position in Q2 2026.
Ascendis Pharma A/S made up 0.03% of Mediolanum International Funds's portfolio in Q2 2026, its #331 holding.
34 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.